CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 4 filers reported holding CAN-FITE BIOPHARMA LTD in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $17,000 | -66.0% | 12,868 | -69.5% | 0.00% | – |
| Q2 2018 | $50,000 | -13.8% | 42,227 | +202.6% | 0.00% | – |
| Q3 2015 | $58,000 | +75.8% | 13,953 | +38.1% | 0.00% | – |
| Q3 2014 | $33,000 | -95.8% | 10,100 | -95.5% | 0.00% | – |
| Q2 2014 | $795,000 | -45.8% | 222,675 | -23.7% | 0.00% | -100.0% |
| Q1 2014 | $1,466,000 | – | 292,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 348,500 | $763,000 | 0.14% |
| MENTA CAPITAL LLC | 12,200 | $27,000 | 0.00% |
| Virtu KCG Holdings LLC | 22,042 | $48,000 | 0.00% |
| MSI Financial Services Inc | 2,000 | $4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 458 | $1,000 | 0.00% |
| UBS Group AG | 5,194 | $11,000 | 0.00% |
| CITIGROUP INC | 17 | $0 | 0.00% |